Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
Center of Evaluation and Treatment of the pain - Saint-Antoine Hospital, Paris, Ile de France, France
Children's National Medical Center, Washington, District of Columbia, United States
Hopital Foch, Suresnes, France
Icahn School of Medicine at Mount Sinai, New York City, New York, United States
Royal Cornhill Hospital, NHS Grampian, Aberdeen, United Kingdom
Icahn School of Medicine at Mount Sinai, New York City, New York, United States
Federal University of São Paulo, São Paulo, Brazil
Imperial College Healthcare NHS Trust, London, United Kingdom
Massachusetts General Hospital, Boston, Massachusetts, United States
Department Anesthesia. Hospital Clinic Barcelona, Barcelona, Spain
Hospital Clinic, Barcelona, Spain
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.